Continuous glucose monitoring is presently used worldwide. Accuracy, precision, durability, invasiveness, and lack of drift of sensors and lag time are key parameters essential to these systems. This article describes a new online minimally invasive biodegradable microsensor for optical, transcutaneous interrogation, which has at least 14 days of functionality.
Method:
Studies were performed in vitro and in vivo on pigs, as well as on type 1 diabetic humans. Functionality has been ensured in laboratory settings, and precision and durability have been tested in vivo. During in vivo studies, venous blood samples were used as reference.
Results were based on one single point calibration per experiment.
Results:
Excellent stability was found in 14-day in vitro trials as well as in vivo in up to 70-hour trials. The overall median relative absolute difference of type 1 diabetic patients was 11.4%. Error grid analysis showed 97.7% of all values in the A+B zone. Comparable results were found in animal studies. No sensor drift was observed in any trial.
Conclusion:
Results point toward the possibility of developing a stable and precise minimally invasive glucose reader for at least 2 weeks of continuous use.
RobinsonMREatonRPHaalandDMKoeppGWThomasEVStallardBRRobinsonPL. Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. Clin Chem.1992;38 (9): 1618–22.
2.
SmallGWArnoldMAMarquardtLA. Strategies for coupling digital filtering with partial least-squares regression: application to the determination of glucose in plasma by Fourier transform near-infrared spectroscopy. Anal Chem.1993;65 (22): 3279–89.
3.
PfutznerACaduffALarbigMSchrepferTForstT. Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoring. Diabetes Technol Ther.2004;6 (4): 435–4.
4.
PottsROTamadaJATierneyMJ. Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev.2002;18Suppl 1: S49–53.
DiemPKaltLHaueterUKrinelkeLFajfrRReihlBBeyerU. Clinical performance of a continuous viscometric affinity sensor for glucose. Diabetes Technol Ther.2004;6 (6): 790–9.
7.
SchultzJSMansouriSGoldsteinIJ. Affinity sensor: a new technique for developing implantable sensors for glucose and other metabolites. Diabetes Care.1982;5 (3): 245–53.
8.
LakowiczJRMaliwalB. Optical sensing of glucose using phase-modulation fluorimetry. Anal Chim Acta.1993;271 (1): 155–64.
9.
RolinskiOJBirchDJSMcCartneyLJPickupJC. Fluorescence resonance energy transfer from allophycocyanin to malachite green. Chem Phys Lett.1999;309 (5): 395–401.
10.
WilkinsEAtanasovP. Glucose monitoring: state of the art and future possibilities. Med Eng Phys.1996;18 (4): 273–88.
11.
KovatchevBPGonder-FrederickLACoxDJClarkeWL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care.2004;27 (8): 1922–8.
12.
KvistPHBieleckiMGerstenbergMRossmeislCJensenHERolinBHasselagerE. Evaluation of subcutaneously-implanted glucose sensors for continuous glucose measurements in hyperglycemic pigs. In vivo.2006;20 (2): 195–203.
13.
MeadowsDLSchultzJS. Design, manufacture and characterization of an optical fiber glucose affinity sensor based on a homogeneous fluorescence energy transfer assay system. Anal Chim Acta.1993;280 (1): 21–30.
14.
RussellRJPishkoMVGefridesCCMcShaneMJCotéGL. A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. Anal Chem.1999;71 (15): 3126–32.
15.
ChinnayelkaSMcShaneMJ. Glucose sensors based on microcapsules containing an orange/red competitive binding resonance energy transfer assay. Diabetes Technol Ther.2006;8 (3): 269–78.
16.
BallerstadtREvansCGowdaAMcNicholsR. In vivo performance evaluation of a transdermal near-infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring. Diabetes Technol Ther.2006;8 (3): 296–311.
17.
BallerstadtRPolakABeuhlerAFryeJ. In vitro long-term performance study of a near-infrared fluorescence affinity sensor for glucose monitoring. Biosens Bioelectron.2004;19 (8): 905–14.
18.
ChickWLWolfDECardulloRA. Method and device for detecting and quantifying glucose in body fluids. United States US patent 5,342,789.
19.
ValdimarssonHVikingsdottirTBangPSaevarsdottirSGudjonssonJEOskarssonOChristiansenMBlouLLaursenIKochC. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol.2004;59 (1): 97–102.
20.
KuijerRBouwmeesterSJDreesMMSurtelDATerwindt-RouwenhorstEAVan Der LindenAJVan BlitterswijkCABulstraSK. The polymer Polyactive as a bone-filling substance: an experimental study in rabbits. J Mater Sci Mater Med.1998;9 (8): 449–55.
21.
BezemerJMRadersmaRGrijpmaDWDijkstraPJFeijenJvan BlitterswijkCA. Zero-order release of lysozyme from poly(ethylene glycol)/poly(buthylene terephthalate) matrices. J Control Release.2000;64 (1–3): 179–92.
22.
LaursenBWNorrildJC. Reagent for detecting an analyte. WO2005/059037A1 patent application.
23.
LihmeAOBoenischT. Water-soluble, polymer-based reagents and conjugates comprising moieties derived from divinyl sulfone. United States patent US 5,543,332.
YuYKristensenJS. Optical sensor for in vivo detection of an analyte. World patent application WO05110207.
26.
ReedAMGildingDK. Biodegradable polymers for use in surgery—poly(ethylene oxide)/poly(ethylene terephthalate) (PEO/PET) copolymers. 2. In vitro degradation. Polymer.1981;22 (4): 499–504.
27.
Handout from poster presented at the ADA 2005 is available from www.precisense.com.
28.
DS/EN ISO 15197. In vitro diagnostics test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus.
29.
WilsonDMBeckRWTamborlaneWVDontchevMJKollmanCChasePFoxLARuedyKJTsalikianEWeinzimerSA. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care.2007;30 (1): 59–64.
30.
WeinsteinRLSchwartzSLBrazgRLBuglerJRPeyserTAMcGarraughGV. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care.2007;30 (5): 1125–30.
